Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 and Older With Asthma

- Asthma
- Completed

Study Title: A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromaxֲ® Versus a Placebo in People 12 Years and Older With Persistent Asthma

Teva Identifier: ABS-AS-301

ClinicalTrials.gov Identifier: NCT01424813

Study Status: Completed

Trial Condition(s): Asthma

Interventions: Drug: Placebo MDPI | Drug: Albuterol MDPI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child, Adult, Older Adult

Age Range: 12 Years and older

Trial Duration: 12/01/2012 - 11/01/2013

Phase: Phase 3

Study Type

Interventional